{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:23:48Z","timestamp":1789226628727,"version":"build-2803163510"},"reference-count":40,"publisher":"Pharmaceutical Society of Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.1248\/bpb.b25-00741","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:10:18Z","timestamp":1775167818000},"page":"636-644","source":"Crossref","is-referenced-by-count":1,"title":["Diterpenes in &lt;i&gt;Aralia cordata&lt;\/i&gt; Rhizomes Suppress the Expression of Proinflammatory and Extracellular Matrix Degradation-Related Genes in ATDC5 Cells"],"prefix":"10.1248","volume":"49","author":[{"given":"Risa","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu, Shiga 525\u20138577, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Airi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu, Shiga 525\u20138577, Japan"},{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Doshisha Women\u2019s College of Liberal Arts, Kyotanabe, Kyoto 610\u20130395, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Nishidono","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu, Shiga 525\u20138577, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu, Shiga 525\u20138577, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhisa","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu, Shiga 525\u20138577, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinobu","family":"Ikeya","sequence":"additional","affiliation":[{"name":"Research Organization of Science and Technology, Ritsumeikan University, Kusatsu, Shiga 525\u20138577, Japan"},{"name":"Faculty of Pharmacy, Daiichi University of Pharmacy, Minami-ku, Fukuoka 815\u20138511, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Nishizawa","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu, Shiga 525\u20138577, Japan"},{"name":"Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Brawijaya, Malang, East Java 65113, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) The Committee on the Japanese Pharmacopoeia. Crude Drugs and Related Drugs. <i>The Japanese Pharmacopoeia, 18th ed.<\/i>, The Minister of Health, Labour and Welfare, Tokyo (2021). https:\/\/www.mhlw.go.jp\/content\/11120000\/000904450.pdf."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Dang NH, Zhang X, Zheng M, Son KH, Chang HW, Kim HP, Bae K, Kang SS. Inhibitory constituents against cyclooxygenases from <i>Aralia cordata<\/i> Thunb. <i>Arch. Pharm. Res.<\/i>, <b>28<\/b>, 28\u201333 (2005).","DOI":"10.1007\/BF02975131"},{"key":"3","unstructured":"3) Lee MK, Hung TM, Min BS, Lee IS, Na MK, Woo MH, Son JK, Kim YH, Choi JS, Bae KH. Quantitative determination of diterpenoids from the Roots of <i>Aralia cordata<\/i>. <i>Natural Product Sciences<\/i>, <b>15<\/b>, 50\u201354 (2009). https:\/\/www.koreascience.kr\/article\/JAKO200914852871187.view?orgId=anpor."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kim JG, Lee JW, Le TPL, Han JS, Kwon H, Lee D, Hong JT, Kim Y, Lee MK, Hwang BY. Diterpenoids and diacetylenes from the roots of <i>Aralia cordata<\/i> with inhibitory effects on nitric oxide production. <i>J. Nat. Prod.<\/i>, <b>84<\/b>, 230\u2013238 (2021).","DOI":"10.1021\/acs.jnatprod.0c00842"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Liu JH, Zschocke S, Reininger E, Bauer R. Comparison of radix Angelicae pubescentis and substitutes\u2014constituents and inhibitory effect on 5-lipoxygenase and cyclooxygenase. <i>Pharm. Biol.<\/i>, <b>36<\/b>, 207\u2013216 (1998).","DOI":"10.1076\/phbi.36.3.207.6343"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kitade H, Sakitani K, Inoue K, Masu Y, Kawada N, Hiramatsu Y, Kamiyama Y, Okumura T, Ito S. Interleukin 1 beta markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells. <i>Hepatology<\/i>, <b>23<\/b>, 797\u2013802 (1996).","DOI":"10.1002\/hep.510230421"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Pautz A, Art J, Hahn S, Nowag S, Voss C, Kleinert H. Regulation of the expression of inducible nitric oxide synthase. <i>Nitric Oxide<\/i>, <b>23<\/b>, 75\u201393 (2010).","DOI":"10.1016\/j.niox.2010.04.007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Colasanti M, Suzuki H. The dual personality of NO. <i>Trends Pharmacol. Sci.<\/i>, <b>21<\/b>, 249\u2013252 (2000).","DOI":"10.1016\/S0165-6147(00)01499-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ozaki H, Nishidono Y, Fujii A, Okuyama T, Nakamura K, Maesako T, Shirako S, Nakatake R, Tanaka K, Ikeya Y, Nishizawa M. Identification of anti-inflammatory compounds from <i>Peucedanum praeruptorum<\/i> roots by using nitric oxide-producing rat hepatocytes stimulated by interleukin 1\u03b2. <i>Molecules<\/i>, <b>28<\/b>, 5076 (2023).","DOI":"10.3390\/molecules28135076"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Cieza A, Causey K, Kamenov K, Hanson SW, Chatterji S, Vos T. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. <i>Lancet<\/i>, <b>396<\/b>, 2006\u20132017 (2021).","DOI":"10.1016\/S0140-6736(20)32340-0"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Mukherjee A, Das B. The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis. <i>Biomater. Biosyst.<\/i>, <b>13<\/b>, 100090 (2024).","DOI":"10.1016\/j.bbiosy.2024.100090"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Luo Y, Sinkeviciute D, He Y, Karsdal M, Henrotin Y, Mobasheri A, \u00d6nnerfjord P, Bay-Jensen A. The minor collagens in articular cartilage. <i>Protein Cell<\/i>, <b>8<\/b>, 560\u2013572 (2017).","DOI":"10.1007\/s13238-017-0377-7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Jia Y, He W, Zhang H, He L, Wang Y, Zhang T, Peng J, Sun P, Qian Y. Morusin ameliorates IL-1\u03b2-induced chondrocyte inflammation and osteoarthritis <i>via<\/i> NF-\u03baB signal pathway. <i>Drug Des. Devel. Ther.<\/i>, <b>14<\/b>, 1227\u20131240 (2020).","DOI":"10.2147\/DDDT.S244462"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Huang X, You Y, Xi Y, Ni B, Chu X, Zhang R, You H. <i>p<\/i>-Coumaric acid attenuates IL-1\u03b2-induced inflammatory responses and cellular senescence in rat chondrocytes. <i>Inflammation<\/i>, <b>43<\/b>, 619\u2013628 (2020).","DOI":"10.1007\/s10753-019-01142-7"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Jaswal AP, Bandyopadhyay A. Re-examining osteoarthritis therapy from a developmental biologist\u2019s perspective. <i>Biochem. Pharmacol.<\/i>, <b>165<\/b>, 17\u201323 (2019).","DOI":"10.1016\/j.bcp.2019.03.020"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Robinson WH, Lepus CM, Wang Q, Raghu H, Mao R, Lindstrom TM, Sokolove J. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. <i>Nat. Rev. Rheumatol.<\/i>, <b>12<\/b>, 580\u2013592 (2016).","DOI":"10.1038\/nrrheum.2016.136"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Xue H, Zhou H, Lou Q, Yuan P, Feng Z, Qiao L, Zhang J, Xie H, Shen Y, Ma Q, Wang S, Zhang B, Ye H, Cheng J, Sun X, Shi P. Urolithin B reduces cartilage degeneration and alleviates osteoarthritis by inhibiting inflammation. <i>Food Funct.<\/i>, <b>15<\/b>, 3552\u20133565 (2024).","DOI":"10.1039\/D3FO03793B"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wang T, He C. Pro-inflammatory cytokines: The link between obesity and osteoarthritis. <i>Cytokine Growth Factor Rev.<\/i>, <b>44<\/b>, 38\u201350 (2018).","DOI":"10.1016\/j.cytogfr.2018.10.002"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ma T, Wen Y, Song X, Hu H, Li Y, Bai H, Zhao M, Gao L. Puerarin inhibits the development of osteoarthritis through antiinflammatory and antimatrix-degrading pathways in osteoarthritis-induced rat model. <i>Phytother. Res.<\/i>, <b>35<\/b>, 2579\u20132593 (2021).","DOI":"10.1002\/ptr.6988"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Baek Y-H, Huh J-E, Lee J-D, Choi D-Y, Park D-S. Effect of <i>Aralia cordata<\/i> extracts on cartilage protection and apoptosis inhibition. <i>Biol. Pharm. Bull.<\/i>, <b>29<\/b>, 1423\u20131430 (2006).","DOI":"10.1248\/bpb.29.1423"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kang OH, Chae HS, Choi JG, Oh YC, Lee YS, Kim JH, Seung MJ, Jang HJ, Bae KH, Lee JH, Shin DW, Kwon DY. <i>Ent<\/i>-Pimara-8(14), 15-dien-19-oic acid isolated from the roots of <i>Aralia cordata<\/i> inhibits induction of inflammatory mediators by blocking NF-\u03baB activation and mitogen-activated protein kinase pathways. <i>Eur. J. Pharmacol.<\/i>, <b>601<\/b>, 179\u2013185 (2008).","DOI":"10.1016\/j.ejphar.2008.10.012"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Lu J, Zhang H, Pan J, Hu Z, Liu L, Liu Y, Yu X, Bai X, Cai D, Zhang H. Fargesin ameliorates osteoarthritis <i>via<\/i> macrophage reprogramming by downregulating MAPK and NF-\u03baB pathways. <i>Arthritis Res. Ther.<\/i>, <b>23<\/b>, 142 (2021).","DOI":"10.1186\/s13075-021-02512-z"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Mei X, Tong J, Zhu W, Zhu Y. lncRNA-NR024118 overexpression reverses LPS-induced inflammatory injury and apoptosis <i>via<\/i> NF-\u03baB\/Nrf2 signaling in ATDC5 chondrocytes. <i>Mol. Med. Rep.<\/i>, <b>20<\/b>, 3867\u20133873 (2019).","DOI":"10.3892\/mmr.2019.10639"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Yamauchi Y, Okuyama T, Ishii T, Okumura T, Ikeya Y, Nishizawa M. Sakuranetin downregulates inducible nitric oxide synthase expression by affecting interleukin-1 receptor and CCAAT\/enhancer-binding protein \u03b2. <i>J. Nat. Med.<\/i>, <b>73<\/b>, 353\u2013368 (2019).","DOI":"10.1007\/s11418-018-1267-x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Kanemaki T, Kitade H, Hiramatsu Y, Kamiyama Y, Okumura T. Stimulation of glycogen degradation by prostaglandin E<sub>2<\/sub> in primary cultured rat hepatocytes. <i>Prostaglandins<\/i>, <b>45<\/b>, 459\u2013474 (1993).","DOI":"10.1016\/0090-6980(93)90122-N"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Inaba H, Yoshigai E, Okuyama T, Murakoshi M, Sugiyama K, Nishino H, Nishizawa M. Antipyretic analgesic drugs have different mechanisms for regulation of the expression of inducible nitric oxide synthase in hepatocytes and macrophages. <i>Nitric Oxide<\/i>, <b>44<\/b>, 61\u201370 (2015).","DOI":"10.1016\/j.niox.2014.12.001"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [<sup>15<\/sup>N]nitrate in biological fluids. <i>Anal. Biochem.<\/i>, <b>126<\/b>, 131\u2013138 (1982).","DOI":"10.1016\/0003-2697(82)90118-X"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Matsui K, Nishizawa M, Ozaki T, Kimura T, Hashimoto I, Yamada M, Kaibori M, Kamiyama Y, Ito S, Okumura T. Natural antisense transcript stabilizes inducible nitric oxide synthase messenger RNA in rat hepatocytes. <i>Hepatology<\/i>, <b>47<\/b>, 686\u2013697 (2008).","DOI":"10.1002\/hep.22036"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ishii T, Okuyama T, Noguchi N, Nishidono Y, Okumura T, Kaibori M, Tanaka K, Terabayashi S, Ikeya Y, Nishizawa M. Antiinflammatory constituents of <i>Atractylodes chinensis<\/i> rhizome improve glomerular lesions in immunoglobulin A nephropathy model mice. <i>J. Nat. Med.<\/i>, <b>74<\/b>, 51\u201364 (2020).","DOI":"10.1007\/s11418-019-01342-3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Jung HA, Lee EJ, Kim JS, Kang SS, Lee J-H, Min B-S, Choi JS. Cholinesterase and BACE1 inhibitory diterpenoids from <i>Aralia cordata<\/i>. <i>Arch. Pharm. Res.<\/i>, <b>32<\/b>, 1399\u20131408 (2009).","DOI":"10.1007\/s12272-009-2009-0"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Okuyama E, Nishimura S, Yamazaki M. Analgesic principles from <i>Aralia cordata<\/i> Thunb. <i>Chem. Pharm. Bull.<\/i>, <b>39<\/b>, 405\u2013407 (1991).","DOI":"10.1248\/cpb.39.405"},{"key":"32","unstructured":"32) Pierre LL, Moses MN. Isolation and characterisation of stigmasterol and \u03b2-sitosterol from <i>Odontonema strictum<\/i> (Acanthaceae). <i>J. Innov. Pharm. Biol. Sci.<\/i>, <b>2<\/b>, 88\u201396 (2015)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Bakrim S, Benkhaira N, Bourais I, Benali T, Lee L-H, El Omari N, Sheikh RA, Goh KW, Ming LC, Bouyahya A. Health benefits and pharmacological properties of stigmasterol. <i>Antioxidants<\/i>, <b>11<\/b>, 1912 (2022).","DOI":"10.3390\/antiox11101912"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Sengprasert P, Kamenkit O, Tanavalee A, Reantragoon R. The immunological facets of chondrocytes in osteoarthritis: a narrative review. <i>J. Rheumatol.<\/i>, <b>51<\/b>, 13\u201324 (2024).","DOI":"10.3899\/jrheum.2023-0816"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Ahmad Khan M, Sarwar AHMdG, Rahat R, Ahmed RS, Umar S. Stigmasterol protects rats from collagen induced arthritis by inhibiting proinflammatory cytokines. <i>Int. Immunopharmacol.<\/i>, <b>85<\/b>, 106642 (2020).","DOI":"10.1016\/j.intimp.2020.106642"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Ningsih FN, Okuyama T, To S, Nishidono Y, Okumura T, Tanaka K, Ikeya Y, Nishizawa M. Comparative analysis of anti-inflammatory activity of the constituents of the rhizome of <i>Cnidium officinale<\/i> using rat hepatocytes. <i>Biol. Pharm. Bull.<\/i>, <b>43<\/b>, 1867\u20131875 (2020).","DOI":"10.1248\/bpb.b20-00416"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Hong R, Kim KS, Choi GM, Yeom M, Lee B, Lee S, Kang KS, Lee HS, Park H-J, Hahm D-H. Continentalic acid rather than kaurenoic acid is responsible for the anti-arthritic activity of Manchurian spikenard <i>in vitro<\/i> and <i>in vivo<\/i>. <i>Int. J. Mol. Sci.<\/i>, <b>20<\/b>, 5488 (2019).","DOI":"10.3390\/ijms20215488"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Possebon MI, Mizokami SS, Carvalho TT, Zarpelon AC, Hohmann MSN, Staurengo-Ferrari L, Ferraz CR, Hayashida TH, de Souza AR, Ambrosio SR, Arakawa NS, Casagrande R, Verri WA Jr. Pimaradienoic acid inhibits inflammatory pain: inhibition of NF-\u03baB activation and cytokine production and activation of the NO-cyclic GMP-protein kinase G-ATP-sensitive potassium channel signaling pathway. <i>J. Nat. Prod.<\/i>, <b>77<\/b>, 2488\u20132496 (2014).","DOI":"10.1021\/np500563b"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Lin S, Lu J, Chen Q, Jiang H, Lou C, Lin C, Wang W, Lin J, Pan X, Xue X. Plantamajoside suppresses the activation of NF-kB and MAPK and ameliorates the development of osteoarthritis. <i>Int. Immunopharmacol.<\/i>, <b>115<\/b>, 109582 (2023).","DOI":"10.1016\/j.intimp.2022.109582"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Perkins ND. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. <i>Oncogene<\/i>, <b>25<\/b>, 6717\u20136730 (2006).","DOI":"10.1038\/sj.onc.1209937"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/4\/49_b25-00741\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:10:47Z","timestamp":1775275847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/4\/49_b25-00741\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00741","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"article-number":"b25-00741"}}